134 related articles for article (PubMed ID: 12095276)
1. Use of CpG island microarrays to identify colorectal tumors with a high degree of concurrent methylation.
Yan PS; Efferth T; Chen HL; Lin J; Rödel F; Fuzesi L; Huang TH
Methods; 2002 Jun; 27(2):162-9. PubMed ID: 12095276
[TBL] [Abstract][Full Text] [Related]
2. High-throughput methylation profiling by MCA coupled to CpG island microarray.
Estécio MR; Yan PS; Ibrahim AE; Tellez CS; Shen L; Huang TH; Issa JP
Genome Res; 2007 Oct; 17(10):1529-36. PubMed ID: 17785535
[TBL] [Abstract][Full Text] [Related]
3. Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays.
Yan PS; Chen CM; Shi H; Rahmatpanah F; Wei SH; Caldwell CW; Huang TH
Cancer Res; 2001 Dec; 61(23):8375-80. PubMed ID: 11731411
[TBL] [Abstract][Full Text] [Related]
4. CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer.
Yan PS; Perry MR; Laux DE; Asare AL; Caldwell CW; Huang TH
Clin Cancer Res; 2000 Apr; 6(4):1432-8. PubMed ID: 10778974
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.
McInnes T; Zou D; Rao DS; Munro FM; Phillips VL; McCall JL; Black MA; Reeve AE; Guilford PJ
BMC Cancer; 2017 Mar; 17(1):228. PubMed ID: 28351398
[TBL] [Abstract][Full Text] [Related]
6. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.
Toyota M; Ho C; Ahuja N; Jair KW; Li Q; Ohe-Toyota M; Baylin SB; Issa JP
Cancer Res; 1999 May; 59(10):2307-12. PubMed ID: 10344734
[TBL] [Abstract][Full Text] [Related]
7. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
[TBL] [Abstract][Full Text] [Related]
9. Methylation target array for rapid analysis of CpG island hypermethylation in multiple tissue genomes.
Chen CM; Chen HL; Hsiau TH; Hsiau AH; Shi H; Brock GJ; Wei SH; Caldwell CW; Yan PS; Huang TH
Am J Pathol; 2003 Jul; 163(1):37-45. PubMed ID: 12819009
[TBL] [Abstract][Full Text] [Related]
10. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
11. Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.
Belshaw NJ; Elliott GO; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1495-501. PubMed ID: 15342451
[TBL] [Abstract][Full Text] [Related]
12. Deoxyribonucleic acid methylation profiling of single human blastocysts by methylated CpG-island amplification coupled with CpG-island microarray.
Huntriss J; Hemmings K; Baskaran P; Hazelwood L; Elder K; Virtanen C; Miller D; Picton HM
Fertil Steril; 2015 Jun; 103(6):1566-71.e1-4. PubMed ID: 25914096
[TBL] [Abstract][Full Text] [Related]
13. Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia.
Lee S; Hwang KS; Lee HJ; Kim JS; Kang GH
Lab Invest; 2004 Jul; 84(7):884-93. PubMed ID: 15122305
[TBL] [Abstract][Full Text] [Related]
14. Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis.
Gitan RS; Shi H; Chen CM; Yan PS; Huang TH
Genome Res; 2002 Jan; 12(1):158-64. PubMed ID: 11779841
[TBL] [Abstract][Full Text] [Related]
15. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
[TBL] [Abstract][Full Text] [Related]
16. Analysis of CpG island methylation using rolling Circle amplification (RCA) product microarray.
Zhao H; Ma X; Li M; Zhou D; Xiao P; Lu Z
J Biomed Nanotechnol; 2011 Apr; 7(2):292-9. PubMed ID: 21702367
[TBL] [Abstract][Full Text] [Related]
17. A microarray-based method for detecting methylated loci.
Hatada I; Kato A; Morita S; Obata Y; Nagaoka K; Sakurada A; Sato M; Horii A; Tsujimoto A; Matsubara K
J Hum Genet; 2002; 47(8):448-51. PubMed ID: 12181645
[TBL] [Abstract][Full Text] [Related]
18. Methylation profiles of genes utilizing newly developed CpG island methylation microarray on colorectal cancer patients.
Kimura N; Nagasaka T; Murakami J; Sasamoto H; Murakami M; Tanaka N; Matsubara N
Nucleic Acids Res; 2005 Mar; 33(5):e46. PubMed ID: 15760842
[TBL] [Abstract][Full Text] [Related]
19. Methylation Linear Discriminant Analysis (MLDA) for identifying differentially methylated CpG islands.
Dai W; Teodoridis JM; Graham J; Zeller C; Huang TH; Yan P; Vass JK; Brown R; Paul J
BMC Bioinformatics; 2008 Aug; 9():337. PubMed ID: 18691414
[TBL] [Abstract][Full Text] [Related]
20. Microarray-based survey of CpG islands identifies concurrent hyper- and hypomethylation patterns in tissues derived from patients with breast cancer.
Piotrowski A; Benetkiewicz M; Menzel U; Díaz de Ståhl T; Mantripragada K; Grigelionis G; Buckley PG; Jankowski M; Hoffman J; Bała D; Srutek E; Laskowski R; Zegarski W; Dumanski JP
Genes Chromosomes Cancer; 2006 Jul; 45(7):656-67. PubMed ID: 16575877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
